Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 41 of 41 entries
Sorted by: Best Match Show Resources per page
Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma.

Annals of surgical oncology

Mansfield SA, McCarville MB, Lucas JT, Krasin MJ, Federico SM, Santana VM, Furman WL, Davidoff AM.
PMID: 34215956
Ann Surg Oncol. 2022 Jan;29(1):661-670. doi: 10.1245/s10434-021-10386-3. Epub 2021 Jul 02.

PURPOSE: Image-defined risk factors (IDRFs) are associated with surgical risks in neuroblastoma. We sought to evaluate the impact of neoadjuvant therapy on IDRFs and associated ability to achieve gross total resection (GTR) of locoregional disease in patients with high-risk...

Cite
Mansfield SA, McCarville MB, Lucas JT, et al. Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma. Ann Surg Oncol. 2021;29(1):661-670doi: 10.1245/s10434-021-10386-3.
Mansfield, S. A., McCarville, M. B., Lucas, J. T., Krasin, M. J., Federico, S. M., Santana, V. M., Furman, W. L., & Davidoff, A. M. (2022). Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma. Annals of surgical oncology, 29(1), 661-670. https://doi.org/10.1245/s10434-021-10386-3
Mansfield, Sara A, et al. "Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma." Annals of surgical oncology vol. 29,1 (2022): 661-670. doi: https://doi.org/10.1245/s10434-021-10386-3
Mansfield SA, McCarville MB, Lucas JT, Krasin MJ, Federico SM, Santana VM, Furman WL, Davidoff AM. Impact of Neoadjuvant Chemotherapy on Image-Defined Risk Factors in High-Risk Neuroblastoma. Ann Surg Oncol. 2022 Jan;29(1):661-670. doi: 10.1245/s10434-021-10386-3. Epub 2021 Jul 02. PMID: 34215956.
Copy Download .nbib Format: NLM
Critical care service delivery across healthcare systems in low-income and low-middle-income countries: protocol for a systematic review.

BMJ open

Lim AG, Kivlehan S, Losonczy LI, Murthy S, Dippenaar E, Lowsby R, Yang MLCLC, Jaung MS, Stephens PA, Benzoni N, Sefa N, Bartlett ES, Chaffay BA, Haridasa N, Velasco BP, Yi S, Contag CA, Rashed AL, McCarville P, Sonenthal PD, Shukur N, Bellou A, Mickman C, Ghatak-Roy A, Ferreira A, Adhikari NK, Reynolds T.
PMID: 34462281
BMJ Open. 2021 Aug 30;11(8):e048423. doi: 10.1136/bmjopen-2020-048423.

INTRODUCTION: Critical care in low-income and low-middle income countries (LLMICs) is an underdeveloped component of the healthcare system. Given the increasing growth in demand for critical care services in LLMICs, understanding the current capacity to provide critical care is...

Cite
Lim AG, Kivlehan S, Losonczy LI, et al. Critical care service delivery across healthcare systems in low-income and low-middle-income countries: protocol for a systematic review. BMJ Open. 2021;11(8):e048423doi: 10.1136/bmjopen-2020-048423.
Lim, A. G., Kivlehan, S., Losonczy, L. I., Murthy, S., Dippenaar, E., Lowsby, R., Yang, M. L. C. L. C., Jaung, M. S., Stephens, P. A., Benzoni, N., Sefa, N., Bartlett, E. S., Chaffay, B. A., Haridasa, N., Velasco, B. P., Yi, S., Contag, C. A., Rashed, A. L., McCarville, P., Sonenthal, P. D., Shukur, N., Bellou, A., Mickman, C., Ghatak-Roy, A., Ferreira, A., Adhikari, N. K., & Reynolds, T. (2021). Critical care service delivery across healthcare systems in low-income and low-middle-income countries: protocol for a systematic review. BMJ open, 11(8), e048423. https://doi.org/10.1136/bmjopen-2020-048423
Lim, Andrew George, et al. "Critical care service delivery across healthcare systems in low-income and low-middle-income countries: protocol for a systematic review." BMJ open vol. 11,8 (2021): e048423. doi: https://doi.org/10.1136/bmjopen-2020-048423
Lim AG, Kivlehan S, Losonczy LI, Murthy S, Dippenaar E, Lowsby R, Yang MLCLC, Jaung MS, Stephens PA, Benzoni N, Sefa N, Bartlett ES, Chaffay BA, Haridasa N, Velasco BP, Yi S, Contag CA, Rashed AL, McCarville P, Sonenthal PD, Shukur N, Bellou A, Mickman C, Ghatak-Roy A, Ferreira A, Adhikari NK, Reynolds T. Critical care service delivery across healthcare systems in low-income and low-middle-income countries: protocol for a systematic review. BMJ Open. 2021 Aug 30;11(8):e048423. doi: 10.1136/bmjopen-2020-048423. PMID: 34462281; PMCID: PMC8407204.
Copy Download .nbib Format: NLM
Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Rodriguez-Galindo C, Krailo MD, Pinto EM, Pashankar F, Weldon CB, Huang L, Caran EM, Hicks J, McCarville MB, Malkin D, Wasserman JD, de Oliveira Filho AG, LaQuaglia MP, Ward DA, Zambetti G, Mastellaro MJ, Pappo AS, Ribeiro RC.
PMID: 33822640
J Clin Oncol. 2021 Aug 01;39(22):2463-2473. doi: 10.1200/JCO.20.02871. Epub 2021 Apr 06.

PURPOSE: Adrenocortical carcinoma (ACC) is a rare aggressive pediatric malignancy with distinct biology. Its treatment follows the principles developed for adults; pediatric-specific studies are scarce.PATIENTS AND METHODS: Prospective single-arm risk-stratified interventional study. Study objectives were (1) to describe the...

Cite
Rodriguez-Galindo C, Krailo MD, Pinto EM, et al. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol. J Clin Oncol. 2021;39(22):2463-2473doi: 10.1200/JCO.20.02871.
Rodriguez-Galindo, C., Krailo, M. D., Pinto, E. M., Pashankar, F., Weldon, C. B., Huang, L., Caran, E. M., Hicks, J., McCarville, M. B., Malkin, D., Wasserman, J. D., de Oliveira Filho, A. G., LaQuaglia, M. P., Ward, D. A., Zambetti, G., Mastellaro, M. J., Pappo, A. S., & Ribeiro, R. C. (2021). Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(22), 2463-2473. https://doi.org/10.1200/JCO.20.02871
Rodriguez-Galindo, Carlos, et al. "Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 39,22 (2021): 2463-2473. doi: https://doi.org/10.1200/JCO.20.02871
Rodriguez-Galindo C, Krailo MD, Pinto EM, Pashankar F, Weldon CB, Huang L, Caran EM, Hicks J, McCarville MB, Malkin D, Wasserman JD, de Oliveira Filho AG, LaQuaglia MP, Ward DA, Zambetti G, Mastellaro MJ, Pappo AS, Ribeiro RC. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol. J Clin Oncol. 2021 Aug 01;39(22):2463-2473. doi: 10.1200/JCO.20.02871. Epub 2021 Apr 06. PMID: 33822640; PMCID: PMC8462560.
Copy Download .nbib Format: NLM
PET and PET/CT in Pediatric Sarcomas.

PET clinics

McCarville MB.
PMID: 27156820
PET Clin. 2008 Oct;3(4):563-75. doi: 10.1016/j.cpet.2009.04.007. Epub 2009 Jul 25.

Because of the rarity of pediatric bone and soft tissue malignancies, it is difficult to validate the role of emerging imaging technologies in their management. The growing body of literature regarding the use of PET and PET/CT in children...

Cite
McCarville MB. PET and PET/CT in Pediatric Sarcomas. PET Clin. 2009;3(4):563-75doi: 10.1016/j.cpet.2009.04.007.
McCarville, M. B. (2008). PET and PET/CT in Pediatric Sarcomas. PET clinics, 3(4), 563-75. https://doi.org/10.1016/j.cpet.2009.04.007
McCarville, M Beth. "PET and PET/CT in Pediatric Sarcomas." PET clinics vol. 3,4 (2008): 563-75. doi: https://doi.org/10.1016/j.cpet.2009.04.007
McCarville MB. PET and PET/CT in Pediatric Sarcomas. PET Clin. 2008 Oct;3(4):563-75. doi: 10.1016/j.cpet.2009.04.007. Epub 2009 Jul 25. PMID: 27156820.
Copy Download .nbib Format: NLM
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, McGahren ED, Feusner J, Rodriguez-Galindo C, Meyers RL, O'Neill AF, Finegold MJ.
PMID: 34874751
J Clin Oncol. 2021 Dec 07;JCO2100803. doi: 10.1200/JCO.21.00803. Epub 2021 Dec 07.

PURPOSE: Small cell undifferentiated (SCU) histology in hepatoblastoma (HB) tumors has historically been associated with a poor prognosis. Tumors from patients enrolled on Children's Oncology Group (COG) study AHEP0731 underwent institutional and central pathologic review for identification of SCU...

Cite
Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, et al. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2021;JCO2100803doi: 10.1200/JCO.21.00803.
Trobaugh-Lotrario, A., Katzenstein, H. M., Ranganathan, S., Lopez-Terrada, D., Krailo, M. D., Piao, J., Chung, N., Randazzo, J., Malogolowkin, M. H., Furman, W. L., McCarville, E. B., Towbin, A. J., Tiao, G. M., Dunn, S. P., Langham, M. R., McGahren, E. D., Feusner, J., Rodriguez-Galindo, C., Meyers, R. L., O'Neill, A. F., & Finegold, M. J. (2021). Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2100803. https://doi.org/10.1200/JCO.21.00803
Trobaugh-Lotrario, Angela, et al. "Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2021): JCO2100803. doi: https://doi.org/10.1200/JCO.21.00803
Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, McGahren ED, Feusner J, Rodriguez-Galindo C, Meyers RL, O'Neill AF, Finegold MJ. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2021 Dec 07;JCO2100803. doi: 10.1200/JCO.21.00803. Epub 2021 Dec 07. PMID: 34874751.
Copy Download .nbib Format: NLM
Showing 37 to 41 of 41 entries